Australian researchers have found a new treatment that can dramatically improve survival rates for a common form of breast ...

On January 17, 2025, the Food and Drug Administration (FDA) approved datopotamab deruxtecan-dlnk a Trop-2-directed antibody ...

The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...

The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...

The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

On Friday, the U.S. Food and Drug Administration (FDA) approved AstraZeneca Plc’s (NASDAQ:AZN) Datroway (datopotamab ...

Many women worry hormonal contraceptives have dangerous side-effects including increased cancer risk. But this perception is often out of proportion with the actual risks.

Breast cancer detection in its early stages significantly improves survival rates, according to medical experts. While ...

"Boy Meets World" star Danielle Fishel said she is finished with radiation treatment for cancer and opened up about the side ...

She was diagnosed with non-hormonal breast cancer. “When you first receive the news, you don’t know anything about it,” Plotner-Moore says. “You have so many questions.” The next six ...

A comprehensive study by the University of Queensland and QIMR Berghofer Medical Research Institute reveals that hormonal ...